Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
H3 histone pseudogene 28 (H3P28)
- Target
- H3P28
- Molecular classification
- Other (pseudogene), Not a receptor, enzyme, transporter, ion channel, or established histone variant
01
Overview
H3 histone pseudogene 28 (H3P28), also referred to by the alias "p40", is an annotated pseudogene in the human genome. Unlike canonical histone genes (such as H3.1, H3.2, H3.3), pseudogenes do not code for functional proteins and are typically remnants of evolutionary events. H3P28 has no established biological function, disease relevance, or recognized role in drug development. The use of the alias "p40" for this gene is potentially confusing as "p40" is more commonly associated with unrelated proteins in oncology and immunology. In summary, H3 histone pseudogene 28 is not a receptor, enzyme, nor a therapeutic target, and there is no evidence of functional or clinical significance attached to this entity.
- Other names
- H3P28p40
02
Mechanism of action
Not applicable. No known mechanisms as it is not a drug target.
03
Biological functions
None established. As a pseudogene, H3P28 is not known to encode a functional protein or carry out cellular functions.
04
Disease associations
None established. There is no evidence in literature or genetic databases associating H3 histone pseudogene 28 with human disease or pathology.
05
Safety considerations
None. There are no relevant safety concerns or challenges mentioned for this pseudogene.
06
Interacting drugs
None. Pseudogenes are not targeted by drugs, and there are no reported interactions.
07
Biomarkers
None. It is not used as a biomarker for patient selection or efficacy monitoring.
Beyond the preview
Go deeper on H3 histone pseudogene 28 (H3P28).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on H3 histone pseudogene 28 (H3P28).